Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis

Wu Xi-li; Sun Wan-sen; Zhang Wang-gang; Qiao Cheng-lin; Ma Qiao-ya; Zhang Xiao-qiang

doi:10.1007/s11655-007-0215-5

Your Location：

Home >

Browse articles >

Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis

Updated：2021-08-27

- Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis
- Chinese Journal of Integrative Medicine Vol. 13, Issue 3, Pages: 215-218(2007)
- Affiliations：
  
  1. Department of Integrated Traditional Chinese and Western Medicine, Shaanxi Province Key TCM Department of Nephrology, The Second Affiliated Hospital, Medical School of Xi’an Jiaotong University,Xi’an,China
  2. Department of Hematology, The Second Affiliated Hospital, Medical School of Xi’an Jiaotong University,China
- Author bio：
- Funds：
  
  Supported by Shaanxi Provincial Administration of TCM (No. 2003158)
- DOI：10.1007/s11655-007-0215-5
  CLC：
- Published：2007，
Scan for full text
Wu, Xl., Sun, Ws., Zhang, Wg. et al. Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis., Chin. J. Integr. Med. 13, 215–218 (2007). https://doi.org/10.1007/s11655-007-0215-5

Wu Xi-li, Sun Wan-sen, Zhang Wang-gang, et al. Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis. [J]. Chinese Journal of Integrative Medicine 13(3):215-218(2007)
Wu, Xl., Sun, Ws., Zhang, Wg. et al. Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis., Chin. J. Integr. Med. 13, 215–218 (2007). https://doi.org/10.1007/s11655-007-0215-5 DOI：

Wu Xi-li, Sun Wan-sen, Zhang Wang-gang, et al. Study on effect of Yishen Capsule (益肾胶囊) in preventing recurrence of chronic glomerulonephritis. [J]. Chinese Journal of Integrative Medicine 13(3):215-218(2007) DOI： 10.1007/s11655-007-0215-5.

摘要

To observe the effect of Yishen Capsule (益肾胶囊

YSC) on preventing the recurrence of chronic glomerulonephritis (CGN) and to explore its mechanism preliminarily. CGN patients were assigned to the treated group (61 cases) and the control group (48 cases) and all of them were orally administered with 4 mg of Perindopril twice a day

but 3 capsules of YSC

thrice a day

were given additionally to patients in the treated group. The therapeutic course for both groups was 18 months. The recurrence rate of CGN at the 6th

12th

and 18th month in the two groups was observed and compared

and the changes of 24-h urinary protein quantity and T-lymphocyte subsets before and after treatment were observed as well. (1) Comparison of recurrence rate between the two groups showed insignificant difference at the 6th month

but it did show significant difference at the 12th and the 18th month

which was significantly decreased in the treated group than in the control group (P<0.05

P<0.01); (2) The 24-h urinary protein quantity at the 18th month decreased significantly in both groups (P<0.05

P<0.01)

but in the treated group was more significant (P<0.01); (3) T-lymphocyte subsets showed no obvious change in the control group after treatment (P>0.05)

while in the treated group

it showed significant increase in CD3

CD4 and CD4/CD8 (P<0.05 or P<0.01) and significant decrease in CD8 (P<0.05)

and also the difference after treatment in T-lymphocyte subsets between the two groups was significant (P<0.05 or P<0.01). YSC has marked effects in reducing the recurrence of CGN and in decreasing urinary protein

and its mechanism might be related with its function in regulating the ratio of T-lymphocyte subsets to enhance the immunity of patients.

Abstract

To observe the effect of Yishen Capsule (益肾胶囊

but 3 capsules of YSC

thrice a day

were given additionally to patients in the treated group. The therapeutic course for both groups was 18 months. The recurrence rate of CGN at the 6th

12th

and 18th month in the two groups was observed and compared

but it did show significant difference at the 12th and the 18th month

which was significantly decreased in the treated group than in the control group (P<0.05

P<0.01); (2) The 24-h urinary protein quantity at the 18th month decreased significantly in both groups (P<0.05

P<0.01)

but in the treated group was more significant (P<0.01); (3) T-lymphocyte subsets showed no obvious change in the control group after treatment (P>0.05)

while in the treated group

it showed significant increase in CD3

CD4 and CD4/CD8 (P<0.05 or P<0.01) and significant decrease in CD8 (P<0.05)

and its mechanism might be related with its function in regulating the ratio of T-lymphocyte subsets to enhance the immunity of patients.

关键词

Yishen Capsulechronic glomerulonephritisrecurrenceT-lymphocyte subsets

Keywords

Yishen Capsulechronic glomerulonephritisrecurrenceT-lymphocyte subsets

references

Wang JY, editor. Internal medicine. Beijing: People’s Medical Publishing House, 2006: 573–574.

Qi CH, Zhang YX, Shen BF. Advances in study on modern pharmacology of Liuwei Dihuang Decoction. Bull Acad Milit Med Sci 2002;26(1):57–61.

Chen LF, Li RX, Cao WF, et al. Effect of high dose of Astragalus membranaceus on serum TNF-α, IL-6 and cellular immune function in patients with chronic glomerulonephritis. J Chongqing Med Univ 2002;27(2):174–176

Shen B, Zheng H, Tian SM. Effect of Injection Radix Astragala on blood rheological changes in patients with chronic nephritis. Shanghai Med Pharm J 1999;20(9):15–16.

Ma J, Peng A, Chen J, et al. Different protective effects of Astragalus memberaneceus on vasopressin system in experimental nephrotic syndrome and congestive heart failure. Chin J Nephrol 1996;12(1):15–18.

Wang JH. Clinical study of Huangqi Injection on proteinuria in patients with chronic glomerulonephritis. Res Tradit Chin Med 2002;18(3):22.

Zeng GX, Liu JY, Xiong JR, et al. Influence of Astragalus Membranaceus (AM) polysaccharide FB on immunologic function of human peripheral blood lymphocyte. Chin J Oncol 1989;11(3):180–182, 183.

Yu H, Li CX, Gong LT, et al. Outlines of pharmacological action of Glycyrrhizae. Progr Mod Biomed 2006;6(4): 83–85.

van Alderwegen IE, Bruijn JA, de Heer E. T cell subsets immunologically-mediated glomerulonephritis. Histol Histopathol 1997;12:241–250.

Yue SY. Detection of the immune function in patients with chronic glomerulonephritis. Med J Qilu 2003;18(3):268–269

Wu XL, Sun WS, Qiao CL, et al. The effect of Yishen Capsule on proteinuria and immune function in patients with chronic glomerulonephritis. J Guangzhou Univ Tradit Chin Med 2004;21(2):100–103.

Wu XL, Qiao CL, Sun WS,et al. Effect of Yishen Capsule on proteinuria and NK cells in patients with chronic glomerulonephritis. J Fourth Mlit Med Univ 2003;24(17):1591.

FULL TEXT LINK

More>

Views

340

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Nodule and eminence on frenulum labii superioris: Diagnostic markers for metastatic colorectal cancer

Preventive effects of Jiedu Granules (解毒颗粒) combined with Cinobufacini Injection (华蟾素注射液) versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: A case-control trial

Clinical study on effect of Astragalus Injection (黄芪注射液) and its immuno-regulation action in treating chronic aplastic anemia

Therapeutic effect of integrative traditional Chinese and western medicine on 51 SARS patients and its influence on their T lymphocyte subsets

Clinical study on effect of shenlong oral liquid combined with radiotherapy in treating nasopharyngeal carcinoma

Related Author

No data

Related Institution

National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital

Tianjin Medical University

Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University

TCM Hospital of Langfang City, Chinese Hemopathic Therapeutic Center of TCM

Beijing Youan Hospital

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰